We are a leading healthcare campus encompassing all fields of health: from healthcare and research to teaching and management.
Professionalism, commitment and research by professionals on the Campus are the key elements in offering patients excellent care.
We are committed to research as a tool to provide solutions to the daily challenges we face in the field of medical healthcare.
Thanks to our healthcare, teaching and research potential, we work to incorporate new knowledge to generate value for patients, professionals and the organization itself.
We generate, transform and transmit knowledge in all areas of the health sciences, helping to train the professionals of the future.
We are defined by our vocation for communication. We invite you to share everything that happens at Vall d'Hebron Barcelona Hospital Campus, and our doors are always open.
Hospital donations
Research donations
Dr. Miravitlles’ career was recognized during the 57th edition of the SEPAR National Congress held in Valencia.
The Spanish Society of Pneumology and Thoracic Surgery (SEPAR) brings together nearly 6,000 specialists in this field. Its main objective is to promote research, training and the dissemination of information on respiratory diseases, which are one of the main causes of death in Europe.
Recently, the 57th edition of the SEPAR National Congress took place. This event is the most important scientific meeting on respiratory diseases held in Spanish and is a unique opportunity to learn about the latest advances in the prevention and treatment of respiratory diseases. It also hosts the Manuel Tapia Conference, a plenary conference named in honour of one of the most prominent figures in 20th century pneumology and the founder of SEPAR. Each year, an internationally renowned pulmonologist is invited to give a lecture in recognition of his or her research career.
In 2024, the guest was Dr Marc Miravitlles, a specialist in pneumology at the Vall d'Hebron University Hospital and a researcher in the Pneumology group at the Vall d'Hebron Research Institute (VHIR). Miravitlles used the lecture to discuss the main milestones of his professional career at Vall d'Hebron in the field of chronic obstructive pulmonary disease (COPD) and alpha-1 antitrypsin deficiency (AATD). This includes the coordination of the three most important national epidemiological studies on COPD and the Spanish clinical practice guideline for the treatment of COPD. He was also a pioneer in the treatment of AATD, founder of the Spanish AATD registry and coordinator of the European clinical guideline for the treatment of AATD and the world's largest AATD registry from the VHIR.
In keeping with tradition, Miravitlles was made an honorary member of SEPAR at this key event, an honour that had previously been bestowed on only one other researcher from Vall d'Hebron, Dr Ferran Morell Brotad.
Pneumology, General Hospital
The acceptance of these terms implies that you give your consent to the processing of your personal data for the provision of the services you request through this portal and, if applicable, to carry out the necessary procedures with the administrations or public entities involved in the processing. You may exercise the mentioned rights by writing to web@vallhebron.cat, clearly indicating in the subject line “Exercise of LOPD rights”. Responsible entity: Vall d’Hebron University Hospital (Catalan Institute of Health). Purpose: Subscription to the Vall d’Hebron Barcelona Hospital Campus newsletter, where you will receive news, activities, and relevant information. Legal basis: Consent of the data subject. Data sharing: If applicable, with VHIR. No other data transfers are foreseen. No international transfer of personal data is foreseen. Rights: Access, rectification, deletion, and data portability, as well as restriction and objection to its processing. The user may revoke their consent at any time. Source: The data subject. Additional information: Additional information can be found at https://hospital.vallhebron.com/es/politica-de-proteccion-de-datos.